Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Clinical trial NCT01027598 · COMPLETED
Trial details
- NCT number
- NCT01027598
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2014-04-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.